Skip to main content
🔬 Research~ Likely78November 5, 2026

AI Startup Aims to Revolutionize Drug Discovery, Skipping Lab Work

Potential Sciences, a UK startup, is using AI and simulated data to accelerate drug development.

Insta's take

"Forget endless lab tests! This AI startup is simulating drug discovery. Could mean faster, cheaper meds for everyone, even for rare diseases."

Potential Sciences, a British startup, is leveraging artificial intelligence to streamline the drug design process. The company plans to create extensive chemical datasets by simulating atomic and molecular interactions based on physics principles. This data will then be used to train AI models and prediction systems, aiming to identify targeted drugs for specific diseases and bypass traditional lab experimentation.

The startup, which launched on November 5, has secured seed funding in the tens of millions of dollars from investors including SovAI, the UK government’s AI venture capital fund, and Twin Path Ventures. Hatem Helal, founder and CEO of Potential Sciences, stated their goal is to make molecules that won't work in the clinic fail fast by improving predictors of their interaction with human biology. This approach seeks to address the current limitation of small datasets, like the Protein Data Bank, which Helal believes are insufficient for advanced AI models.

If successful, this method could significantly accelerate the development of new treatments and make it economically viable for pharmaceutical companies to pursue drugs for rare conditions. Academics like Alan Fersht from the University of Cambridge recognize the potential of simulation-based approaches to revolutionize drug development by accurately calculating molecular interactions. The company aims to make more bespoke treatments possible, tailored to unique human biology.

Why Insta thinks this matters

This AI-driven approach could drastically reduce the time and cost associated with drug discovery, opening doors for new treatments, especially for rare diseases. For businesses in pharmaceuticals and biotech, it signals a potential shift in R&D strategies towards computational methods.

Sources
Wired↗

Relevant tools

Lever
ATS and CRM platform with AI-powered candidate matching and ...
StackScore Tools™65›
Make
Visual automation platform connecting apps into multi-step w...
StackScore Tools™68›
Pi
Inflection's empathetic personal AI focused on supportive, c...
StackScore Tools™54›
Viable
AI analysis tool that summarizes customer feedback from surv...
StackScore Tools™32›
Insta's Weekly Digest — every Sunday
Insta Tool Finder

Find the right AI tool for your business

Chat with Insta and get matched to the right tool in seconds.

Try Insta Tool Finder →